N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives
- 10 March 2005
- journal article
- review article
- Published by Springer Nature in Psychopharmacology
- Vol. 179 (1) , 30-53
- https://doi.org/10.1007/s00213-005-2199-1
Abstract
No abstract availableKeywords
This publication has 167 references indexed in Scilit:
- Amino acid transporter SNAT5 localizes to glial cells in the rat brainGlia, 2004
- Effect of d-serine on a delayed match-to-place task for the water mazeBehavioural Brain Research, 2004
- Non-opioid actions of opioid peptidesLife Sciences, 2004
- Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: A case‐control studyAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2004
- Calcium/calmodulin‐dependent kinase II is involved in the facilitating effect of clozapine on NMDA‐ and electrically evoked responses in the medial prefrontal cortical pyramidal cellsSynapse, 2003
- NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humansSynapse, 2001
- Identification of Genes from a Schizophrenia-Linked Translocation Breakpoint RegionGenomics, 2001
- The Nagging Question of the Function ofN-AcetylaspartylglutamateNeurobiology of Disease, 1997
- Clozapine treatment increases serum glutamate and aspartate compared to conventional neurolepticsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- Clinical Experience With Excitatory Amino Acid Antagonist DrugsStroke, 1995